European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other … European Journal of Preventive Cardiology 19 (4), 585-667, 2012 | 7080 | 2012 |
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and … F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ... European heart journal 41 (2), 255-323, 2020 | 4667 | 2020 |
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with … FLJ Visseren, F Mach, YM Smulders, D Carballo, KC Koskinas, M Bäck, ... European heart journal 42 (34), 3227-3337, 2021 | 4575 | 2021 |
Alogliptin after acute coronary syndrome in patients with type 2 diabetes WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ... New England journal of medicine 369 (14), 1327-1335, 2013 | 3129 | 2013 |
Cardiorenal end points in a trial of aliskiren for type 2 diabetes HH Parving, BM Brenner, JJV McMurray, D De Zeeuw, SM Haffner, ... New England Journal of Medicine 367 (23), 2204-2213, 2012 | 1647 | 2012 |
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity K Malmberg, L Rydén, H Wedel, K Birkeland, A Bootsma, K Dickstein, ... European heart journal 26 (7), 650-661, 2005 | 1496 | 2005 |
Guidelines: Editor's choice: 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of … MF Piepoli, AW Hoes, S Agewall, C Albus, C Brotons, AL Catapano, ... European heart journal 37 (29), 2315, 2016 | 627* | 2016 |
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control MR Cowie, M Fisher Nature Reviews Cardiology 17 (12), 761-772, 2020 | 567 | 2020 |
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1 … S Heller, J Buse, M Fisher, S Garg, M Marre, L Merker, E Renard, ... The Lancet 379 (9825), 1489-1497, 2012 | 473 | 2012 |
Diabetes, left ventricular systolic dysfunction, and chronic heart failure MR MacDonald, MC Petrie, NM Hawkins, JR Petrie, M Fisher, R McKelvie, ... European heart journal 29 (10), 1224-1240, 2008 | 343 | 2008 |
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo … RR Holman, RL Coleman, JCN Chan, JL Chiasson, H Feng, J Ge, ... The lancet Diabetes & endocrinology 5 (11), 877-886, 2017 | 338 | 2017 |
Increasing physical activity in people with type 2 diabetes A Kirk, N Mutrie, P MacIntyre, M Fisher Diabetes care 26 (4), 1186-1192, 2003 | 318 | 2003 |
Prevalence of symptoms and signs of shoulder problems in people with diabetes mellitus SJ Thomas, C McDougall, IDM Brown, MC Jaberoo, A Stearns, R Ashraf, ... Journal of shoulder and elbow surgery 16 (6), 748-751, 2007 | 239 | 2007 |
Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial D Preiss, SM Lloyd, I Ford, JJ McMurray, RR Holman, P Welsh, M Fisher, ... The lancet Diabetes & endocrinology 2 (2), 116-124, 2014 | 220 | 2014 |
Effects of a 12-month physical activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes A Kirk, N Mutrie, P MacIntyre, M Fisher Diabetologia 47, 821-832, 2004 | 193 | 2004 |
Promoting and maintaining physical activity in people with type 2 diabetes AF Kirk, N Mutrie, PD MacIntyre, MB Fisher American journal of preventive medicine 27 (4), 289-296, 2004 | 177 | 2004 |
Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica AW Hoes, S Agewall, C Albus, C Brotons, AL Catapano, MT Cooney, ... Revista Española de Cardiología 69 (10), 939. e1-939. e87, 2016 | 149 | 2016 |
Guía europea sobre prevención de la enfermedad cardiovascular en la práctica clínica (versión 2012) J Perk, G De Backer, H Gohlke, I Graham, Z Reiner, WMM Verschuren, ... Revista española de cardiología 65 (10), 937, 2012 | 149 | 2012 |
European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease … J Perk, G De Backer, H Gohlke, I Graham, Z Reiner, M Verschuren, ... Eur Heart J 33 (13), 1635-1701, 2012 | 147 | 2012 |
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal–bolus treatment with mealtime insulin aspart in Type 1 … BW Bode, JB Buse, M Fisher, SK Garg, M Marre, L Merker, E Renard, ... Diabetic medicine 30 (11), 1293-1297, 2013 | 130 | 2013 |